This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, J. A.
Right arrow Articles by Maloney, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, J. A.
Right arrow Articles by Maloney, P. C.

 Previous Article  |  Next Article 

Journal of Bacteriology, July 2002, p. 3756-3758, Vol. 184, No. 13
0021-9193/02/$04.00+0     DOI: 10.1128/JB.184.13.3756-3758.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Pyridoxal 5-Phosphate Inhibition of Substrate Selectivity Mutants of UhpT, the Sugar 6-Phosphate Carrier of Escherichia coli

Jason A. Hall and Peter C. Maloney*

Department of Physiology, Johns Hopkins University Medical School, Baltimore, Maryland 21205

Received 4 January 2002/ Accepted 10 April 2002


arrow
ABSTRACT
 
In the sugar phosphate transporter UhpT, gain-of-function derivatives that prefer phosphoenolpyruvate (PEP) as substrate have an uncompensated lysine residue on transmembrane segment 11. We show here that these variants are also highly susceptible to substrate-protectable inhibition by covalent modification of lysine with pyridoxal 5-phosphate. The chemical requirements of this interaction provide evidence that the gain-of-function phenotype results from the pairing of the uncompensated lysines in these mutants with the anionic carboxyl group of PEP.


arrow
TEXT
 
The major facilitator superfamily (MFS) is a large collection of evolutionarily related secondary transport systems that use the chemiosmotic energy generated by the movement of ions down their electrochemical gradients to drive the transport of small solutes (9, 13, 16, 19, 20). Members of the MFS, while showing great diversity in both substrate specificity and kinetic mechanism, all share a common structural theme characterized by the presence of approximately 12 transmembrane segments thought to transverse the membrane in an {alpha}-helical conformation (9, 13, 19). Because there is as yet no crystallographic structure to guide an analysis, the study of helix relationships and helix function in members of the MFS has relied heavily on site-directed mutagenesis and the modification chemistry it affords.

We have applied these techniques to the study of UhpT, the Pi-linked hexose phosphate antiport carrier of Escherichia coli (14, 15, 21). In previous work, Asp388 and Lys391, located in the 11th transmembrane segment (TM11) of this transporter, were identified as participants in an intrahelical salt bridge (7). Study of this ion pair indicated that both positions 388 and 391 might lie on the UhpT translocation pathway since D388C and K391C single-cysteine variants are sensitive to the membrane impermeant, thiol-reactive probe p-chloromercuribenzosulfonate but are unaffected when treatment is in the presence of substrate (8). Further analysis indicated that these two positions might also function as determinants of substrate specificity. Derivatives having an uncompensated cationic charge (the D388C and D388K/K391C variants) are gain-of-function mutants in which substrate preference is strongly biased in favor of phosphoenolpyruvate (PEP), a substrate that carries one more negative charge than sugar 6-phosphate (8). Here, by using the lysine-reactive agent pyridoxal 5-phosphate (PLP), we provide evidence that the lysine introduced into these gain-of-function variants serves as a receptor for the reactive aldehyde of PLP, suggesting that this lysine is also poised to interact with the anionic carboxyl brought into the translocation pathway by PEP.

Strain RK5000 [araD139 {Delta}(argF-lac)U169 relA1 rpsL150 thi gyrA219 non metE780 {Delta}(ilvB-uhpABCT')2056 recA] served as the host for tests of function of plasmid-encoded UhpT (23). Plasmid pTrc(HisC0S6) encodes the histidine-tagged, cysteineless UhpT that served as the parent for the D388C and D388K/K391C derivatives described in this study (7). To assay transport function, overnight cultures were diluted 200-fold into either Luria-Bertani broth plus antibiotics (100 µg of streptomycin/ml, 100 µg of ampicillin/ml) or M63 minimal medium (17) (pH 7) containing thiamine (2 µg/ml), required amino acids (50 µg/ml), necessary antibiotics, and 0.2% glucose as the carbon source. Cells were grown at 37°C to a density of 2 x 108 to 5 x 108 cells/ml, harvested by centrifugation, and then washed twice and resuspended in buffer A (50 mM morpholinepropanesulfonic acid [MOPS]-K, 100 mM K2SO4, 1 mM MgSO4, pH 7) at an optical density at 660 nm of 1.4, which is equivalent to about 2 x 109 cells/ml. After equilibration at room temperature, tests of Pi transport ([32P]KPi) was obtained from Perkin Elmer Life Sciences) were initiated by adding a 1/20th volume of labeled substrate (final concentration, 100 µM). At indicated times, aliquots were removed for filtration on Millipore filters (0.45-µm pore size) followed by two washes with 5 ml of buffer A lacking MgSO4. To monitor PLP inhibition of glucose-6-phosphate (G6P) and PEP transport, cells were first incubated with and without PLP (1 µM to 1 mM) for 10 min at room temperature to allow Schiff base formation with any exposed lysine residues (11). Any Schiff base(s) formed was reduced by a subsequent 10-min exposure to 15 mM NaBH4 to yield the chemically stable product N-phosphopyridoxal-lysine (11). Aliquots were then filtered to remove additives, and after two washes with 5 ml of buffer A, tests of transport were initiated by overlaying cells (on the filter) with buffer A containing 50 µM radiolabeled G6P or PEP ([14C]G6P and [14C]PEP were obtained from Perkin Elmer Life Sciences and Amersham Pharmacia Biotech, respectively). To assess substrate protection, the same protocol was used, except that cells were incubated with either 1 mM unlabeled substrate or 1 mM unlabeled substrate plus PLP before tests of transport.

As a cofactor, PLP functions by facilitating an array of mechanistically related reactions, almost always involving an interaction with a lysine residue during the course of catalysis (10, 22). It is this selectivity that makes PLP a useful reagent for analyzing both the location and function of lysyl groups in membrane transport proteins (1-3, 6, 12, 18), including UhpT. However, since PLP resembles UhpT's natural substrates in overall size, shape, and charge, it was important to first determine whether this compound is transported by cysteineless UhpT and its D388C and D388K/K391C derivatives. Since these variants display normal levels of Pi self-exchange (8) (Fig. 1), we could address this issue by measuring the effectiveness with which added substrate (G6P, PEP, or PLP) caused the loss of Pi during heterologous exchange of internal substrate (Fig. 1). As expected, the addition of G6P, but not of PEP, led to a marked loss of internal phosphate in cells carrying cysteineless UhpT, while PEP caused nearly equivalent Pi efflux from the D388C and D388K/K391C variants. By contrast, reduced Pi efflux occurred when a low-affinity substrate was added (G6P for the D388C and D388K/K391C gain-of-function mutants and PEP for cysteineless UhpT). In these latter cases, we attribute residual Pi efflux to the use of these substrates at a concentration (1 mM) at or above their likely Km values for transport (8). PLP induced an even smaller efflux of Pi, suggesting that significant Pi/PLP exchange does not occur for the UhpT variants analyzed here. A low level of Pi efflux might be attributed to PLP functioning as an inhibitor of transport, and in the case of both the D388C and D388K/K391C mutants, this may be the case (see below). However, PLP acts as a poor inhibitor of G6P transport by cysteineless UhpT (Table 1), indicating that the residual Pi efflux exhibited by this strain upon addition of PLP is likely due to this compound being, at best, a poor UhpT substrate (Km >> 1 mM).



View larger version (18K):
[in this window]
[in a new window]
 
FIG. 1. Substrate transport by UhpT and its derivatives. Pi transport by cysteineless (A), D388K/K391C (B), and D388C (C) UhpT. Cells (grown in M63 minimal medium to repress other phosphate systems) were incubated with radiolabeled Pi. At the time point indicated by the arrow, the control tube was divided into four portions and each portion was given either additional buffer A ({blacksquare}) or buffer A containing 1 mM unlabeled Pi ({blacktriangleup}), G6P ({square}), PEP ({circ}), or PLP (•). Data from three separate trials were normalized to the transport values at the time of addition (Pi accumulation at this time ranged from 80 to 120 nmol/mg of protein) and are shown as means ± standard errors.


View this table:
[in this window]
[in a new window]
 
TABLE 1. UhpT function in TM11 variants exposed to PLP

Our next tests evaluated the response of each UhpT variant to the inhibition of G6P and PEP transport before and after covalent modification of accessible lysines by reduction of any Schiff base formed between PLP and its target(s). As judged by G6P and PEP transport, exposure to reductant alone (NaBH4) had no significant effect on UhpT function (Table 1). We next examined the effect of exposure to PLP, with or without subsequent NaBH4 treatment, including an estimation of the PLP concentration yielding 50% inhibition (K0.5). Those variants with an uncompensated lysine at either position 388 or 391 were strongly inhibited by PLP, showing K0.5 values in the range of 10 to 40 µM (Fig. 2; Table 1) not dependent upon NaBH4 reduction. By contrast, cysteineless UhpT, in which Lys391 pairs with Asp388, responded poorly to PLP treatment (K0.5 of about 1 to 2 mM). For the PLP-responsive derivatives, we then determined whether protection was afforded by coincubation with PEP and G6P, using a probe concentration near its K0.5 value. Both variants (D388C and D388K/K391C) benefited from the presence of substrate, showing an 80 to 90% retention of UhpT function (Table 1). Collectively, these data imply that PEP and G6P, as well as PLP, interact with the 388/391 region of UhpT.



View larger version (10K):
[in this window]
[in a new window]
 
FIG. 2. Inhibition of UhpT variants by PLP. Inhibition of G6P (cysteineless UhpT [{blacksquare}]) and PEP (D388C [•] and D388K/K391C [{square}] derivatives) transport after treatment with PLP (1 µM to 1 mM) and NaBH4. Data from three independent experiments were normalized to the transport values after treatment with NaBH4 alone and are shown as means ± standard errors using the method of Dixon (4). K0.5 values for UhpT variants under these conditions are shown in Table 1.

What conclusions can we draw from these experiments? First, even though PLP is not transported by UhpT, that PLP interacts at position 388 or 391 shows that it has a distribution within UhpT comparable to that of G6P and PEP. Second, these findings offer independent evidence in support of the hypothesis that both positions 388 and 391 are likely to be on the translocation pathway and, therefore, can serve as determinants of substrate selectivity. Thus, while the presence of an uncompensated lysine at either of these positions does not preclude PEP or G6P entrance onto the translocation pathway, it does bias transport preference toward the former and away from the latter. Finally, we speculate that our findings may let us address the orientation a substrate adopts as it moves through UhpT. We have previously shown that positions 388 and 391 lie deep within the hydrophobic core of UhpT (8) while those residues (Arg46 and Arg275) required for recognition of the phosphoryl group at the substrate C-6 (or C-5) position are found near the periplasmic surface (5). Here, we present evidence indicating that an uncompensated lysine at either position 388 or 391, in much the same way that it serves as a receptor for the carboxyl moiety of PEP, provides the amide component for Schiff base formation with the C-4 aldehyde of PLP. Together, these findings strongly suggest that substrates orient themselves within UhpT with their C-1 positions pointed toward the cytoplasm and phosphate groups toward the periplasm.


arrow
ACKNOWLEDGMENTS
 
This work was supported by grant GM24195 from the National Institutes of Health.

We thank Robert Kadner for the gift of strain RK5000.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Department of Physiology, Johns Hopkins School of Medicine, 725 N. Wolfe St., Baltimore, MD 21205-2185. Phone: (410) 955-8325. Fax: (410) 955-4438. E-mail: pmaloney{at}jhmi.edu. Back


arrow
REFERENCES
 
    1
  1. Anderberg, S. J. 1995. Topological disposition of lysine 943 in native Na+/K(+)-transporting ATPase. Biochemistry 34:9508-9516.[CrossRef][Medline]
  2. 2
  3. Bogner, W., H. Aquila, and M. Klingenberg. 1986. The transmembrane arrangement of the ADP/ATP carrier as elucidated by the lysine reagent pyridoxal 5-phosphate. Eur. J. Biochem. 161:611-620.[Medline]
  4. 3
  5. Dierks, T., R. Stappen, A. Salentin, and R. Kramer. 1992. Probing the active site of the reconstituted aspartate/glutamate carrier from bovine heart mitochondria: carbodiimide-catalyzed acylation of a functional lysine residue. Biochim. Biophys. Acta 1103:13-24.[Medline]
  6. 4
  7. Dixon, M. 1953. The determination of enzyme inhibitor constants. Biochem. J. 55:170-171.[Medline]
  8. 5
  9. Fann, M.-C., A. H. Davies, A. Varadhachary, T. Kuroda, C. Sevier, T. Tsuchiya, and P. C. Maloney. 1998. Identification of two essential arginine residues in UhpT, the sugar phosphate antiporter of Escherichia coli. J. Membr. Biol. 164:187-195.[CrossRef][Medline]
  10. 6
  11. Gremse, D. A., B. Dean, and R. S. Kaplan. 1995. Effect of pyridoxal 5'-phosphate on the function of the purified mitochondrial tricarboxylate transport protein. Arch. Biochem. Biophys. 316:215-219.[CrossRef][Medline]
  12. 7
  13. Hall, J. A., M.-C. Fann, and P. C. Maloney. 1999. Altered substrate selectivity in a mutant of an intrahelical salt bridge in UhpT, the sugar phosphate carrier of Escherichia coli. J. Biol. Chem. 274:6148-6153.[Abstract/Free Full Text]
  14. 8
  15. Hall, J. A., and P. C. Maloney. 2001. Transmembrane segment 11 of UhpT, the sugar phosphate carrier of Escherichia coli, is an {alpha}-helix that carries determinants of substrate selectivity. J. Biol. Chem. 276:25107-25113.[Abstract/Free Full Text]
  16. 9
  17. Henderson, P. J. F. 1993. The 12-transmembrane helix transporters. Curr. Opin. Cell Biol. 5:708-721.[CrossRef][Medline]
  18. 10
  19. John, R. A. 1995. Pyridoxal phosphate-dependent enzymes. Biochim. Biophys. Acta 1248:81-96.[CrossRef][Medline]
  20. 11
  21. Lunblad, R. L. 1991. Chemical reagents for protein modification. CRC Press, Boca Raton, Fla.
  22. 12
  23. Majima, E., M. Ishida, S. Miki, Y. Shinohara, and H. Terada. 2001. Specific labeling of the bovine heart mitochondrial phosphate carrier with fluorescein 5-isothiocyanate: roles of Lys185 and putative adenine nucleotide recognition site in phosphate transport. J. Biol. Chem. 276:9792-9799.[Abstract/Free Full Text]
  24. 13
  25. Maloney, P. C. 1994. Bacterial transporters. Curr. Opin. Cell Biol. 6:571-582.[CrossRef][Medline]
  26. 14
  27. Maloney, P. C., S. V. Ambudkar, V. Anantharam, L. A. Sonna, and A. Varadhachary. 1990. Anion-exchange mechanisms in bacteria. Microbiol. Rev. 54:1-17.[Abstract/Free Full Text]
  28. 15
  29. Maloney, P. C., and T. H. Wilson. 1996. Ion-coupled transport and transporters, p. 1130-1148. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. ASM Press, Washington, D.C.
  30. 16
  31. Marger, M. D., and M. H. Saier. 1993. A major superfamily of transmembrane facilitators that catalyse uniport, symport, and antiport. Trends Biochem. Sci. 18:13-20.[CrossRef][Medline]
  32. 17
  33. Miller, J. H. 1972. Experiments in molecular genetics. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
  34. 18
  35. Natuzzi, D., L. Daddabbo, V. Stipani, A. R. Cappello, D. V. Miniero, L. Capobianco, and I. Stipani. 1999. Inactivation of the reconstituted oxoglutarate carrier from bovine heart mitochondria by pyridoxal 5'-phosphate. J. Bioenerg. Biomembr. 31:535-541.[CrossRef][Medline]
  36. 19
  37. Pao, S. S., I. T. Paulsen, and M. H. Saier, Jr. 1998. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62:1-34.[Abstract/Free Full Text]
  38. 20
  39. Poolman, B., and W. N. Konings. 1993. Secondary solute transport in bacteria. Biochim. Biophys. Acta 1183:5-39.[Medline]
  40. 21
  41. Sonna, L. A., S. V. Ambudkar, and P. C. Maloney. 1988. The mechanism of glucose 6-phosphate transport by Escherichia coli. J. Biol. Chem. 263:6625-6630.[Abstract/Free Full Text]
  42. 22
  43. Walsh, C. 1979. Enzymatic reaction mechanisms. W. H. Freeman and Company, San Francisco, Calif.
  44. 23
  45. Weston, L. A., and R. J. Kadner. 1987. Identification of Uhp polypeptides and evidence for their role in exogenous induction of the sugar phosphate transport system of Escherichia coli K-12. J. Bacteriol. 169:3546-3555.[Abstract/Free Full Text]


Journal of Bacteriology, July 2002, p. 3756-3758, Vol. 184, No. 13
0021-9193/02/$04.00+0     DOI: 10.1128/JB.184.13.3756-3758.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hall, J. A., Maloney, P. C. (2005). Altered Oxyanion Selectivity in Mutants of UhpT, the Pi -linked Sugar Phosphate Carrier of Escherichia coli. J. Biol. Chem. 280: 3376-3381 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hall, J. A.
Right arrow Articles by Maloney, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hall, J. A.
Right arrow Articles by Maloney, P. C.